- Home
- IMXI vs KROS Comparison
IMXI vs KROS Comparison
Compare IMXI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- KROS
- Stock Information
- Founded
- IMXI 1994
- KROS 2015
- Country
- IMXI United States
- KROS United States
- Employees
- IMXI N/A
- KROS N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- KROS Health Care
- Exchange
- IMXI Nasdaq
- KROS Nasdaq
- Market Cap
- IMXI 619.2M
- KROS 589.8M
- IPO Year
- IMXI N/A
- KROS 2020
- Fundamental
- Price
- IMXI $21.04
- KROS $10.86
- Analyst Decision
- IMXI Buy
- KROS Buy
- Analyst Count
- IMXI 6
- KROS 11
- Target Price
- IMXI $27.50
- KROS $45.33
- AVG Volume (30 Days)
- IMXI 139.4K
- KROS 2.0M
- Earning Date
- IMXI 02-25-2025
- KROS 02-26-2025
- Dividend Yield
- IMXI N/A
- KROS N/A
- EPS Growth
- IMXI 21.49
- KROS N/A
- EPS
- IMXI 1.80
- KROS N/A
- Revenue
- IMXI $665,673,000.00
- KROS $651,000.00
- Revenue This Year
- IMXI $2.65
- KROS $303.39
- Revenue Next Year
- IMXI $2.82
- KROS N/A
- P/E Ratio
- IMXI $11.72
- KROS N/A
- Revenue Growth
- IMXI 3.79
- KROS 8037.50
- 52 Week Low
- IMXI $16.17
- KROS $9.78
- 52 Week High
- IMXI $23.28
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- IMXI 55.16
- KROS 20.25
- Support Level
- IMXI $19.73
- KROS $9.78
- Resistance Level
- IMXI $20.64
- KROS $16.49
- Average True Range (ATR)
- IMXI 0.47
- KROS 0.92
- MACD
- IMXI 0.04
- KROS 0.97
- Stochastic Oscillator
- IMXI 78.23
- KROS 14.52
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.